A Case Report: Hürthle Cell Carcinoma of the Thyroid Gland
Department of General Surgery, Karadeniz Tecnical University, Faculty of Medicine, , TRABZON
Anahtar Kelimeler: Hürthle hücreli karsinom, tiroid bezi, Hürthle cell carcinoma, thyroid gland.
4.505 görüntülenme 5.125 indirme
Ameliyat sonrası subtotal tiroidektomi doku materyalinin histopatolojik incelemesi sonucu Hürthle hücreli karsinomu tanısı konulan bir vaka takdim edilmektedir. Takiben, total tiroidektomi yapıldı, hormon replasmanı ve boyun bölgesine eksternal radiyoterapi ile tedavi edildi.
Giriş
Olgu Sunumu
On physical examination of the neck, there was multinodular enlargement of the thyroid gland. Thyroid function tests were within normal limits. Thyroid ultrasonography revealed multinodularity of the both thyroid lobes with hypoechogenic cystic lesions scattered throughout the gland. Thyroid scintigraphy demonstrated a cold area toward the upper pole of the right lobe with diffuse distribution of the isotopes in the left lobe. Throughout a collar skin crease incision a subtotal thyroidectomy was performed. Histopathological examination of the removed thyroid tissue reported Hürthle cell carcinoma in the left lobe of the gland showing capsular and vascular invasion. Whole body scintigraphy demonstrated residual thyroid tissue remnant in the neck with no metastatic lesions. Therefore, excision of the remnant of the thyroid tissue was completed with total thyroidectomy that was documented scintigraphically after the second operation. The patient was further treated by hormonal replacement therapy with thyroxine and external radiotherapy to the neck.
Tartışma
Total thyroidectomy is the mainstay of treatment for HCC. Some authors suggest that HCC spreads to the cervical lymph nodes more frequently than follicular cancer and ipsilateral central neck lymphadenectomy is to be considered in the management of these patients 7,13. This reported patient was treated with total thyroidectomy at the second operation. However, no lymph node could be palpated at the neck and cervical lymph dissection was not found necessary.
Furthermore, it is well established that patients with nodal metastases, vascular invasion, soft-tissue invasion, or DNA aneuploidy may benefit from adjuvant external radiotherapy to the neck, especially when the tumor fails to concentrate radioiodine 7,14. Therefore, the present patient was referred to Department of Radiotherapy for adjuvant external radiation to the neck.
Thyroid ultrasonography, scintigraphy, and fine needle aspiration cytology (FNAC) are the main routine diagnostic aids used in the assessment of thyroid gland lesions. Thyroid scintigraphy demonstrated a cold area toward the upper pole of the right lobe that raised the possibility of thyroid cancer. Though FNAC was not performed in this particular case, however it would not be of much help if it had been applied for the scintigraphically localized cold area. Since, postoperative histopathological examination of the removed thyroid tissue by subtotal thyroidectomy surprisingly revealed Hürthle cell carcinoma in the contralateral (left) lobe of the clinically suspected site (right lobe) for the cancer. This malignant lesion would otherwise be missed by not only with FNAC to the suspicious cold area at the right lobe, but also with right hemithyroidectomy, if this operation had been selected in the management of this particular patient. Therefore, subtotal thyroidectomy should be a standard treatment model not only to remove the contained necrotic, degenerative nodules that misshapen the normal structure of the gland causing pressure symptoms but most importantly to exclude the possibility of malignant lesions in these multinodular goiters.
Kaynaklar
1)Masood S, Auguste LJ, Westerband A, Belluco C, Valderema E, Attie J. Differential oncogenic expression in thyroid follicular and Hürthle cell carcinomas. Am J Surg 1993;166: 366368.
2)Sadler GP, Clark HO, Van heerden JA, Farley DR. Thyroid and parathyroid. In: Schwartz SI, Shires GT, Spencer FC, et al ( Editors). Principles of Surgery. 7. Baskı, New York, USA, McGraw-Hall companies, 1999: 1685-1686.
3)Watson RG, Brennan MD, Goellner JR, Van Heerden JA, Mc Conabey WM, Taylor WF. Invasive Hürthle cell carcinoma of the thyroid: Natural history and management. Mayo Clin Proc 1984;59: 851855.
4)Grossman RF, Clark OH. Hürthle cell carcinoma. Cancer Control 1997;4: 1317.
5)Ditkoff BA, Chabot J, Jin S, Feind C. Hürthle cell cancer of the thyroid: The incidence of multifocal and bilateral disease. Thyroidol Clin Exp 1995;7: 4953.
6)Rosen IB, Luk S, Katz I. Hürthle cell tumor behavior: Dilemma and resolution. Surgery 1985;98: 777783.
7)Foote RL, Brown PD, Garces YL, McIver B, Kasperbauer JL. Is there a role for radiation therapy in the management of hürthle cell carcinoma? Inter J Rad Onco Bio Phys 2003;56:1067-1072.
8)McDonald M, Sanders LE, Silverman ML, Chan HS, Buyske J. Hürthle cell carcinoma: prognostic factors and results of surgical treatment. Surgery 1996;120:10041005.
9)Har-El G, Hadar T, Segal K, Levy R, Sidi J. Hürthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer 1986;57:16131617.
10)Grebe SKG, Hay ID. Follicular thyroid cancer. Endocrinol Metab Clin North Am 1995;24:761801.
11)Grossman RF, Tezelman S, Novosolov F, et al. Total thyroidectomy and central neck lymph node dissection: Treatment of choice for Hürthle cell carcinoma. In: 10th International Congress of Endocrinology, San Francisco, California. The Endocrine Society; June 1215, 1996. p 646
12)Caplan RH, Abellera RM, Kisken WA. Hürthle cell neoplasms of the thyroid gland: reassessment of functional capacity. Thyroid 1994;4:243248.
13)Martins RG, Caplan RH, Lambert PJ, Rooney B, Kisken WA. Management of thyroid cancer of follicular cell origin. JAC Surg 1997;185: 404-414.
14)Van Tol KM, de Vries EG, Dullaart RP, Links TP. Differentiated thyroid carcinoma in the elderly. Critic Rev Onco Hemato 2001;38:79-91.
© 2004 Fırat Tıp Dergisi. Tüm hakları saklıdır.

